SGLT2 Inhibitors in Patients with Chronic Kidney Disease and Heart Disease: A Literature Review
By: Abhishek Kansara, Faiza Mubeen and Jawairia Shakil
Authors
ahkansara@houstonmethodist.org
Houston Methodist Hospital, Houston, Texas; Weill Cornell College of Medicine, Ithaca, New York; Texas A&M College of Medicine, Houston, Texas
Jawairia Shakil
Houston Methodist Hospital, Houston, Texas; Weill Cornell College of Medicine, Ithaca, New York; Texas A&M College of Medicine, Houston, Texas
DOI: https://doi.org/10.14797/mdcvj.1120 | Journal eISSN: 1947-6108
Language: English
Page range: 62 - 72
Submitted on: Apr 19, 2022
Accepted on: Jun 28, 2022
Published on: Sep 6, 2022
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2022 Abhishek Kansara, Faiza Mubeen, Jawairia Shakil, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.